2C-G


2C-G is a psychedelic phenethylamine of the 2C family. First synthesized by Alexander Shulgin, it is sometimes used as an entheogen. It has structural and pharmacodynamic properties similar to 2C-D and Ganesha. Like many of the phenethylamines in PiHKAL, 2C-G and its homologs have only been taken by Shulgin and a small test group, making it difficult to ensure completeness when describing effects.

Chemistry

2C-G is 3,4-dimethyl-2,5-dimethoxyphenethylamine, with the formula.

Dosage and effects

In Shulgin's book PiHKAL, the dosage range is listed as 20 to 35 mg. Effects are similar to the related Ganesha, and are extremely long lasting; the duration is 18–30 hours. Visual effects are muted or absent, and it is described in PiHKAL as an "insight-enhancer". Unlike other members of the 2C family, 2C-G is nearly as potent as its amphetamine cousin.

Homologs

Several homologs of 2C-G were also synthesized by Shulgin. These include 2C-G-3, 2C-G-5, and 2C-G-N. Some, such as 2C-G-1, 2C-G-2, 2C-G-4, and 2C-G-6 are possible to synthesize in principle but impossible or extraordinarily difficult to do so in practice.
2C-G-1CAS: not available
The synthesis of this compound has not been reported
2C-G-2CAS: not available
The synthesis of this compound has not been reported
2C-G-3CAS: 207740-19-0
Dosage: 16–25 mg
Duration: 12–24 hours
Effects: Some visual effects. General euphoria with an underlying sense of paranoia.
2C-G-4CAS: 952006-59-6
Synthesized but not tested.
2C-G-5CAS: 207740-20-3
Dosage: 10–16 mg
Duration: 32–48 hours
Effects: Similar to 2C-B for some users. General euphoria, often leading to tiredness.
2C-G-6CAS: not available
The synthesis of this compound has not been reported
2C-G-NCAS: 207740-21-4
Dosage: 20–40 mg
Duration: 20–30 hours
Effects: Stimulation similar to that caused by amphetamines. General sense of unease or unfriendliness for most. 2C-G-N is sometimes called 2C-NPH due to the Naphthalene portion of the molecule.

Legal status

Canada

As of October 31, 2016; 2C-G is a controlled substance in Canada.

United Kingdom

2C-G and all other compounds featuring in PiHKAL are Class A drugs in the United Kingdom.

United States

2C-G and all of its homologs are unscheduled in the United States, but possession and sales of 2C-G and homologs might be prosecuted under the Federal Analog Act because of their close structural similarities to 2C-B, which is a Schedule I controlled substance.